Profil
Karolina Vilval currently works at Oncopeptides Incentive AB, as Director and Sedana Medical AB, as General Counsel from 2022.
Ms. Vilval also formerly worked at Gilead Sciences Sweden AB, as Associate Director-Legal from 2019 to 2020, Biovitrum AB, as Head-Legal Affairs, Oncopeptides AB, as General Counsel from 2020 to 2022, and Swedish Orphan Biovitrum AB, as Head-Legal Affairs from 2005 to 2019.
Ms. Vilval received her graduate degree from the University of Stockholm.
Postes actifs de Karolina Vilval
| Sociétés | Poste | Début |
|---|---|---|
| SEDANA MEDICAL AB | Conseiller Juridique Général | 01/08/2022 |
Oncopeptides Incentive AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Karolina Vilval
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOPEPTIDES AB | Conseiller Juridique Général | 01/08/2022 |
Gilead Sciences Sweden AB | Conseiller Juridique Général | 01/03/2020 |
| SWEDISH ORPHAN BIOVITRUM AB | Conseiller Juridique Général | 01/05/2019 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Conseiller Juridique Général | - |
Formation de Karolina Vilval
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Gilead Sciences Sweden AB | |
Sedana Medical AB
Sedana Medical AB Medical SpecialtiesHealth Technology Develops and wholesales medical devices and drugs | Health Technology |
Oncopeptides Incentive AB |
















